DOT-C: A cluster randomised feasibility trial evaluating d irectly o bserved an t i-H C V therapy in a population receiving opioid substitute therapy from community pharmacy

Abstract Background Direct-acting antiviral therapy (DAAs) for hepatitis C infection (HCV) have a much smaller burden of treatment than interferon-based regimes, require less monitoring and are very effective. New pathways are required to increase access to treatment amongst people prescribed opioid...

Full description

Bibliographic Details

Published in:	The International journal of drug policy Vol. 47; pp. 126 - 136
Main Authors:	Radley, Andrew, Tait, Jan, Dillon, John F
Format:	Journal Article
Language:	English
Published:	01-09-2017
Subjects:	Internal Medicine Medical Education Clinical pathways Directly acting antiviral drugs Hepatitis C Feasibility trial Community pharmacy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!